Biotech Values

[DewDiligence]

To lift the partial FDA clinical hold on IDX184, the FDA will need to see no safety signal in the 28-day data for the first 30 patients to enroll in the phase-2b trial in treatment-naïve genotype-1 patients slated to begin in 2H11. In other words, it will likely be 2012 before the partial clinical hold can be lifted. (Source: Today’s CC)